Spin-outer, the key for emerging companies in Biotechnology

　Spin-outer escapes the warmth of big business and throws himself into a biotech venture; an irregular series of reports on the people who hold the key to biotech industry growth. This time, NANO MRNA's CEO Akinaga, who is taking on the challenge of developing mRNA medicine, is introduced in a two-part series.
https://miyata-bio.net/column/0000346/